Abivax S.A. July 23, 2025 - by Joey Ramson Shares of $ABVX have gone absolutely hyperbolic today, up nearly 600%, after releasing great, “potentially disruptive” results for its experimental ulcerative colitis treatment, Obefazimod. Share this article:
